231 related articles for article (PubMed ID: 8993844)
41. Converting enzyme inhibitors differentially affect expression of genes of the renin-angiotensin system.
Keuneke C; Yacullo R; Sugiura M; Mall G; Metzger R; Ganten D
Clin Exp Hypertens; 1995 Apr; 17(3):551-74. PubMed ID: 7613528
[TBL] [Abstract][Full Text] [Related]
42. Hypertensive and hypotensive mice produced by the introduction and disruption of genes on the renin-angiotensin system.
Murakami K; Tanimoto K; Sugaya T; Fukamizu A
Blood Press Suppl; 1996; 2():36-40. PubMed ID: 8913538
[TBL] [Abstract][Full Text] [Related]
43. Ontogenetic regulation of mouse Ren-2d renin gene in transgenic hypertensive rats, TGR(mREN2)27.
Zhao Y; Bader M; Kreutz R; Fernandez-Alfonso M; Zimmermann F; Ganten U; Metzger R; Ganten D; Mullins JJ; Peters J
Am J Physiol; 1993 Nov; 265(5 Pt 1):E699-707. PubMed ID: 8238495
[TBL] [Abstract][Full Text] [Related]
44. Angiotensinogen concentrations and renin clearance : implications for blood pressure regulation.
Bohlender J; Ménard J; Ganten D; Luft FC
Hypertension; 2000 Mar; 35(3):780-6. PubMed ID: 10720595
[TBL] [Abstract][Full Text] [Related]
45. The transition from experimental to clinical pharmacology: the renin-angiotensin paradigm.
Ganten D
J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S14-29. PubMed ID: 7507536
[TBL] [Abstract][Full Text] [Related]
46. Transgenic rats in hypertension research.
Wagner J; Zeh K; Paul M
J Hypertens; 1992 Jul; 10(7):601-5. PubMed ID: 1321185
[No Abstract] [Full Text] [Related]
47. Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade.
Böhm M; Lippoldt A; Wienen W; Ganten D; Bader M
Mol Cell Biochem; 1996; 163-164():217-21. PubMed ID: 8974060
[TBL] [Abstract][Full Text] [Related]
48. [Developmental biotechnology and hypertension--emphasis on renin-angiotensin system].
Shimada S; Fukamizu A; Murakami K
Nihon Rinsho; 1993 Jun; 51(6):1562-7. PubMed ID: 8320835
[TBL] [Abstract][Full Text] [Related]
49. Influence of up-regulated renin-angiotensin system on the exploration, anxiety-related behavior and object recognition.
Krsková L; Vrabcová M; Talarovicová A; Zeman M
Acta Biol Hung; 2009 Dec; 60(4):369-83. PubMed ID: 20015829
[TBL] [Abstract][Full Text] [Related]
50. Differential development of early hypertension in heterozygous transgenic TGR(mREN2)27 rats.
Kreutz R; Fernandez-Alfonso MS; Paul M; Peters J
Clin Exp Hypertens; 1998 Apr; 20(3):273-82. PubMed ID: 9605382
[TBL] [Abstract][Full Text] [Related]
51. Effects of nephrectomy and adrenalectomy on the renin-angiotensin system of transgenic rats TGR(mRen2)27.
Tokita Y; Franco-Saenz R; Mulrow PJ; Ganten D
Endocrinology; 1994 Jan; 134(1):253-7. PubMed ID: 8275941
[TBL] [Abstract][Full Text] [Related]
52. Lifelong angiotensin-converting enzyme inhibition, pressure natriuresis, and renin-angiotensin system gene expression in transgenic (mRen-2)27 rats.
Lippoldt A; Gross V; Bohlender J; Ganten U; Luft FC
J Am Soc Nephrol; 1996 Oct; 7(10):2119-29. PubMed ID: 8915971
[TBL] [Abstract][Full Text] [Related]
53. Transgenic TGR(mREN2)27 rats as a model for disturbed circadian organization at the level of the brain, the heart, and the kidneys.
Lemmer B; Witte K; Enzminger H; Schiffer S; Hauptfleisch S
Chronobiol Int; 2003 Jul; 20(4):711-38. PubMed ID: 12916722
[TBL] [Abstract][Full Text] [Related]
54. Development of inverse circadian blood pressure pattern in transgenic hypertensive TGR(mREN2)27 rats.
Witte K; Lemmer B
Chronobiol Int; 1999 May; 16(3):293-303. PubMed ID: 10373099
[TBL] [Abstract][Full Text] [Related]
55. Transgenic animals: new approaches to hypertension research.
Mullins JJ; Ganten D
J Hypertens Suppl; 1990 Dec; 8(7):S35-7. PubMed ID: 2095394
[TBL] [Abstract][Full Text] [Related]
56. Molecular biology of the renin-angiotensin system: implications for hypertension and beyond.
Samani NJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S1-6. PubMed ID: 1725015
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27.
Montgomery HE; Kiernan LA; Whitworth CE; Fleming S; Unger T; Gohlke P; Mullins JJ; McEwan JR
J Hypertens; 1998 May; 16(5):635-43. PubMed ID: 9797175
[TBL] [Abstract][Full Text] [Related]
58. Transgenic animals as models to study the regulation and functional role of the renin-angiotensin system.
Paul M; Wagner J
Exp Nephrol; 1994; 2(2):128. PubMed ID: 8082005
[No Abstract] [Full Text] [Related]
59. Different effects of antihypertensive agents on cardiac and vascular hypertrophy in the transgenic rat line TGR(mRen2)27.
Brosnan MJ; Devlin AM; Clark JS; Mullins JJ; Dominiczak AF
Am J Hypertens; 1999 Jul; 12(7):724-31. PubMed ID: 10411370
[TBL] [Abstract][Full Text] [Related]
60. Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene.
Baltatu O; Cayla C; Iliescu R; Andreev D; Jordan C; Bader M
J Am Soc Nephrol; 2002 Nov; 13(11):2681-7. PubMed ID: 12397037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
